13F

Stock

Bolt Biotherapeutics, Inc.

BOLT · held by 21 managers

Reported value

$3.3M

Holders

21

+0 new · −1 exited

Holders’ est. mark

$468

Price effect on 3 books still in the name

Largest holder

$753.1K

Sofinnova Investments, Inc.

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Sofinnova Investments, Inc.137.7K$753.1KHeld
Pivotal bioVenture Partners Investment Advisor LLC94.6K$517.1KHeld
Vivo Capital, LLC72.4K$396KHeld
Nan Fung Group Holdings Ltd58.3K$319KHeld
Renaissance Technologies55K$300.9KHeld
T3 Companies, LLC38K$207.8KHeld
Board of Trustees of The Leland Stanford Junior University36K$196.7KHeld
Pfizer Inc31.3K$171.2KHeld
NANO CAP NEW MILLENNIUM GROWTH FUND L P20.5K$112.1KHeld
GEODE CAPITAL MANAGEMENT, LLC18.8K$103.1KHeld
Shay Capital LLC15.3K$83.5KHeld
Vanguard10.2K$55.8KHeld
BlackRock, Inc.9.71K$53.1KHeld
MORGAN STANLEY3.13K$17.1K$463Added$463
Tower Research Capital LLC (TRC)723$3.95KHeld
UBS Group AG515$2.82KHeld
CITIGROUP INC256$1.4KHeld
JPMORGAN CHASE & CO42$230Held
BANK OF AMERICA CORP /DE/31$169$4Added$4
SBI Securities Co., Ltd.10$55Held
BARCLAYS PLC6$33$1Added$1

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.